Ferrer, Lanileah G.
HRN: 24-53-48 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2024
CEFUROXIME 1.5GM (VIAL)
04/01/2024
04/01/2024
IV
1.5grams
PTOR
For Diagnostic D&C
Checking Final Appropriateness
03/31/2024
CEFUROXIME 500MG (TAB)
03/31/2024
04/07/2024
PO
500mg
BID X 7 Days
UTI
Waiting Final Action
03/31/2024
CEFUROXIME 1.5GM (VIAL)
03/31/2024
04/01/2024
IV
1.5gms
Q8hrs
UTI
Waiting Final Action
04/01/2024
CLINDAMYCIN 300MG (CAP)
04/01/2024
04/08/2024
PO
300mg
TID
S/p Manual Vacuum Aspiration Biopsy
Checking Final Appropriateness